Description
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients. The Company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections.
bioMérieux's LUMED offers advanced clinical decision support tools for antimicrobial stewardship and infection prevention. It helps healthcare providers identify non-optimal antibiotic prescriptions and monitor healthcare-associated infections, enhancing clinical workflows and patient outcomes. LUMED APSS optimizes antimicrobial prescriptions, reducing misuse and resistance. LUMED ZINC streamlines infection prevention practices, promptly identifying outbreaks and multi-drug resistant organisms. LUMED integrates seamlessly into healthcare systems, driving better healthcare and economic results
Hall
HWL2025
Booth number
F18
Business sector
Medical Supplies & Equipment
Technologies, IT and Information Systems
Website
https://www.biomerieux.com/
